Peptide Department · Pattaya
Physician-guided peptide therapy at our Peptide Department walk-in clinic in Nongprue, Pattaya — among the most-extensively studied recovery peptides in preclinical literature for gut-lining and tendon repair. Pharmaceutical-grade, lab-verified inside Thailand, physician-guided. Get a personalized protocol quote via WhatsApp in around two minutes.
Dedicated
Peptide Department with its own protocols and follow-up structure.
Pharmacy-verified
Compounded under licensed Bangkok pharmacy, COA-certified.
Cold-chain
Continuous 2–8°C handling entirely within Thailand.
Lab-Verified
Every batch verified via HPLC and mass spectrometry before dispense.
The Science
BPC-157 is a stable gastric pentadecapeptide — a 15-amino-acid sequence derived from a protective protein in human gastric juice. It is one of the most-extensively studied recovery peptides in preclinical literature, with mechanism work spanning angiogenesis, gut-mucosal protection and nitric-oxide signalling in animal and cell-culture models.
Pillar 1 · preclinical
Angiogenesis (VEGFR2)
In preclinical models — chick chorioallantoic membrane assay, rat hind-limb ischaemia and human endothelial-cell cultures — BPC-157 upregulated VEGFR2 and activated the VEGFR2–Akt–eNOS signalling pathway, with increased vessel density and accelerated blood-flow recovery (Hsieh et al., J Mol Med (Berl), 2017 · PMID 27847966).
Pillar 2 · preclinical review
Gut mucosa & IBD research
Sikiric-group narrative reviews summarise BPC-157 effects across GI lesions and reference the sponsor-led PL-14736 (Pliva, Croatia) Phase II program for inflammatory bowel disease (Sikiric et al., Inflammopharmacology, 2006 · PMID 17186181). Primary clinical-trial results from PL-14736 remain unpublished in peer-reviewed form.
Pillar 3 · preclinical
Nitric-oxide / eNOS pathway
In isolated rat aorta and human endothelial (HUVEC) cultures, BPC-157 produced endothelium- and NO-dependent vasorelaxation (blocked by L-NAME and haemoglobin) and phosphorylated Src, Caveolin-1 and eNOS, reducing Cav-1/eNOS binding (Hsieh et al., Sci Rep, 2020 · PMID 33051481).
BPC-157 is research-grade and not FDA-approved. The findings above are from preclinical animal studies, in-vitro cell-culture experiments and narrative review articles — not approved indications. Provided under physician guidance for research use only.
Documented Research Targets
Peer-reviewed research has examined BPC-157 in two primary anatomical contexts: gut-lining recovery (IBD-adjunct research, preclinical animal models and Sikiric-group review articles) and tendon and connective-tissue repair (Achilles model, in-vitro and in-vivo rat studies). These are research-grade contexts, not FDA-approved uses.
All contexts above are research-grade. BPC-157 is not FDA-approved for any therapeutic claim. Provided at TRT Bangkok Peptide Department for medically-supervised research use only.
Why in-Thailand sourcing matters
Direct sourcing — no overseas shipping risk
Our Asia-based pharmaceutical-grade supplier route stays within Thailand. Intercontinental shipping adds 18–72 hours of cold-chain transition points; our pharmacy-to-clinic workflow avoids them.
Licensed pharmacist-verified supply chain
Every batch is verified via HPLC and mass spectrometry to confirm potency and authenticity prior to dispense. Asia's leading licensed and accredited compounding pharmacy in Bangkok with 10+ years of hospital and clinic supply experience.
Medical-grade, certified manufacturing
Manufactured in a Class 1000 cleanroom-certified facility under CODEX GMP-certified standards, ISO 9001:2015 Quality Management System, and HACCP-certified safety controls throughout production.
Local regulatory compliance
Dispensed under Thai pharmacy law with continuous 2–8°C cold-chain logistics to the clinic and to your address.
From manufacturing release to your sealed delivery, BPC-157 stays under continuous temperature control inside Thailand — no transcontinental shipping, no anonymous online seller in the middle.
Our quality standards
Asia's leading licensed and accredited compounding pharmacy in Bangkok — with 10+ years of hospital and clinic supply experience. Every vial released to TRT Bangkok carries a Certificate of Analysis traceable to its production lot.
Research Protocol
At TRT Bangkok we provide BPC-157 exclusively as a subcutaneous protocol — the route most commonly used in preclinical pharmacokinetic work and the cleanest dose control for research use. Your first dose is physician-guided at our Pattaya walk-in clinic; the rest you handle at home with WhatsApp medical support throughout.
How the protocol works
Your first injection takes place at our Pattaya clinic — physician-guided, demonstrated step-by-step so you leave confident.
After that, you continue at home with daily 5-minute subcutaneous doses, on your own schedule.
WhatsApp medical support runs throughout your protocol — no extra appointments needed unless you want one.
Dose
250–500 mcg / day
Split morning and evening. Your peptide protocols team sets the exact daily target based on indication context and prior response.
Duration
4–6 weeks
Standard course for acute research-protocol use like tendon strain or gut irritation. Extendable to 12 weeks for chronic indications under monthly medical review.
Route
Subcutaneous only
Rotate sites between abdomen, thigh and deltoid. Single-use sterile equipment included in your kit; sharps disposal container provided.
Walk-in path · default
Visit our Nongprue clinic for your initial guided dose — physician-observed for safety and full technique demo. You leave with your protocol, sterile kit and direct WhatsApp line to our peptide protocols team.
Book clinic visit →Remote path · secondary
Thailand-wide cold-chain delivery plus an online consultation with our peptide protocols team. Technique demo is delivered via secure video before your first dose; WhatsApp medical support throughout your protocol.
WhatsApp remote setup →Research-protocol parameters are individualized by our peptide protocols team based on indication context, body weight and prior response. Peptide therapy requires medical supervision; individual results vary.
What's Included
One transparent quote covers everything from your first lab-verified vial to your final WhatsApp check-in. No hidden fees, no surprise add-ons.
Lab-verified pharmaceutical-grade BPC-157 vials
HPLC and mass-spectrometry verified before dispense. Each vial carries a Certificate of Analysis traceable to its production lot.
Cold-chain delivery within Thailand
Continuous 2–8°C from pharmacy to your address — no overseas leg, no anonymous online seller in the chain.
Sterile starter kit
Everything you need for the full course — included in your one transparent quote.
Initial consultation + medical onboarding
Medical-history review, baseline check and a full hands-on demo at our Pattaya walk-in clinic — or by secure video if you're outside Pattaya.
WhatsApp medical support throughout
Direct line to our peptide protocols team for the full duration of your course — same-day reply during clinic hours.
Quality-controlled manufacturing
Compounded in a Class 1000 cleanroom-certified facility under CODEX GMP, ISO 9001:2015 and HACCP-certified safety controls.
Get your quote
Send us your indication and we will return your full protocol cost — vials, kit, cold-chain delivery, consultation and medical support — as one transparent total. No commitment, no spam.
Pharmaceutical-grade research-peptide therapy — investment varies by protocol length. Most protocols run 4–6 weeks for acute use, up to 12 weeks for chronic.
Walk-in clinic · Pattaya
No referral needed. Walk in for your initial guided dose at our Pattaya clinic — physician-observed, with a full hands-on demo. BPC-157 research-peptide therapy at TRT Bangkok is provided through a dedicated Peptide Department with its own protocols, communication system and follow-up structure.
Outside Pattaya?
We deliver BPC-157 Thailand-wide under cold-chain, with online consultation and video-guided demo. Same medical supervision, same lab-verified supply — just remote.
WhatsApp remote setup →Patient Reviews
Real reviews from real patients on our Google Business Profile — updated regularly.
Read all reviews on Google →Research we reference
Every mechanism claim and anatomical context on this page traces back to a PubMed-indexed publication. We do not make FDA-approval claims; this is research-grade evidence presented under physician guidance.
Most BPC-157 evidence to date is preclinical (cell and animal studies). One sponsor-led Phase II program (PL-14736, Pliva, Croatia) explored ulcerative colitis in the 2000s; primary clinical-trial results remain unpublished in peer-reviewed form. Citations on this page link to verified PubMed entries. BPC-157 is not FDA-approved and is offered as research-grade peptide therapy under physician guidance.
Angiogenesis · VEGFR2 pathway
Hsieh MJ, et al. J Mol Med (Berl), 2017 · PMID 27847966
"Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation." Preclinical: in-vitro endothelial (HUVEC) tube-formation + chick CAM assay + rat hind-limb ischaemia. Underpins the VEGFR2 angiogenesis pillar above. PubMed
Gut mucosa · IBD-adjunct research
Sikiric P, et al. Inflammopharmacology, 2006 · PMID 17186181
"Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response." Sikiric-group narrative review of preclinical GI/IBD data plus reference to the PL-14736 Phase II trial program conducted by Pliva (Croatia); standalone clinical-trial primary-outcome paper has not been published in peer-reviewed form. PubMed
Tendon outgrowth · cell survival · migration
Chang CH, et al. J Appl Physiol, 2011 · PMID 21030672
"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Preclinical: in-vitro rat tendon fibroblasts + ex-vivo tendon explant outgrowth. Underpins the tendon panel of the anatomy map above. PubMed
Achilles tendon-to-bone integration
Krivic A, et al. J Orthop Res, 2006 · PMID 16583442
"Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation." Preclinical: in-vivo rat surgical Achilles detach-reattach model. Underpins the tendon-to-bone subline of the anatomy map above. PubMed
Nitric-oxide / eNOS pathway
Hsieh MJ, et al. Sci Rep, 2020 · PMID 33051481
"Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway." Preclinical: ex-vivo isolated rat aorta + in-vitro human endothelial (HUVEC) Src/Cav-1/eNOS phosphorylation. Endothelium- and NO-dependent vasorelaxation, blocked by L-NAME and haemoglobin. Underpins the NO/eNOS pillar described in the mechanism section. PubMed
All findings cited on this page are from preclinical animal studies, in-vitro cell-culture experiments, or narrative review articles. BPC-157 is not FDA-approved. There are no completed peer-reviewed Phase III human clinical-trial publications for BPC-157 as of June 2026.
Frequently Asked
BPC-157 is a research peptide studied in preclinical animal and cell models for tendon and ligament repair, gut-lining recovery, and inflammatory bowel conditions. Preclinical research has reported angiogenic (blood-vessel forming) effects via VEGFR2 upregulation. It is not FDA-approved and is provided through our Peptide Department for medically-supervised research use only.
At TRT Bangkok we provide BPC-157 exclusively as a subcutaneous injection — typically 250 to 500 mcg per day, split morning and evening. Your initial guided injection is performed at our Nongprue walk-in clinic for safety and injection-technique demo. Subsequent injections you administer yourself at home, with WhatsApp medical support throughout your protocol.
Standard four to six weeks for acute research-protocol use such as tendon strain or gut irritation. Extended courses run up to twelve weeks for chronic indications like inflammatory bowel disease research-protocol use or post-surgery recovery research, with monthly medical check-ins.
BPC-157 is research-grade and protocol-individualized — pricing depends on your indication, dose and course length. We provide a personalized quote in around two minutes via WhatsApp. Every quote includes the full protocol cost: lab-verified vials, cold-chain delivery, sterile injection kit, initial consultation, injection-technique demo and WhatsApp medical support throughout. No hidden fees — transparent total. Most protocols run four to six weeks for acute use, twelve weeks for chronic.
Through Asia's leading licensed and accredited compounding pharmacy in Bangkok with over ten years of hospital and clinic supply experience. Raw materials are verified by HPLC and mass spectrometry, manufacturing follows CODEX GMP and ISO 9001:2015 standards in a Class 1000 cleanroom-certified facility with HACCP-certified safety controls, and the supply chain stays inside Thailand under continuous 2–8°C cold-chain handling — no overseas shipping risk.
BPC-157 has a favorable preclinical safety profile in published animal studies (e.g. Sikiric et al., Inflammopharmacology 2006, PMID 17186181). The most reported user-effects in research-context are mild injection-site reactions. Our peptide protocols team reviews your medical history and current prescriptions before any protocol begins.
BPC-157 and TB-500 are frequently combined in research-use protocols, though clinical evidence for combination effects in humans is limited. We assess combination protocols case-by-case after medical-history review; ask via WhatsApp for combo pricing.
How We Verify · Where To Find Us
Product is checked by HPLC and mass spectrometry through our licensed compounding pharmacy and kept under continuous 2–8°C cold-chain — verified at the point of dispense, not from an anonymous online seller.
Licensed medical facility
License No. 72509 · Chon Buri, Thailand. Open Monday–Saturday, 8:00 am – 6:00 pm.
★★★★★ 5.0 from 23 verified Google reviews · Read them on Google
389/203 Moo 12, Nongprue, Bang Lamung, Pattaya, Chon Buri 20150 · +66 84 224 9559
Our Peptide Department covers the full clinical-research spectrum — recovery, growth-hormone support, skin and longevity, libido and visceral fat.
BPC-157 at TRT Bangkok is provided through a dedicated Peptide Department under the TRT Bangkok umbrella. This department has its own protocols, communication system and follow-up structure. Compounded under licensed Bangkok pharmacy · independent peptide protocols · physician-guided. All claims subject to current Thai medical regulations · individual eligibility · physician's discretion. References available on request. Peptide therapy requires medical supervision; not for use during pregnancy. Individual results vary. BPC-157 is a research-grade peptide and is not FDA-approved.
Ready to start BPC-157 in Pattaya?
